文献速递母胎医学产科

结构性异常胎儿人群中的全外显子组测序

Whole Exome Sequencing in a Population of Fetuses With Structural Anomalies.
PubMed 文献 · Prenat Diagn · 2025-01-01

单中心回顾性病历审查纳入2012年5月至2023年12月接受全外显子组测序(ES)的397例异常胎儿,总体ES诊断率为34.3%;单发异常胎儿为31.6%,累及4个及以上主要器官系统胎儿为42.6%;接受尸检的死胎中38.6%获得遗传学诊断,既往有受累患儿的家庭诊断率为45.5%。作者认为ES应提供给存在先天性异常或发生胎儿死亡/终止妊娠的妊娠,其诊断率高度依赖全面表型分析。

要点

  • 397例异常胎儿总体ES诊断率为34.3%。
  • 单发异常胎儿ES诊断率31.6%,4个及以上主要器官系统受累胎儿为42.6%。
  • 接受尸检的死胎中38.6%获得遗传学诊断,既往有受累患儿家庭诊断率45.5%。

核心结论

  • ES是重要工具,应提供给存在先天性异常或发生胎儿死亡或终止妊娠的妊娠,其产前诊断率高度依赖全面表型分析。
  • 获得诊断性ES结果后,后续妊娠可选择生殖技术和检测方案。

研究设计与样本

  • 单中心回顾性病历审查,纳入2012年5月至2023年12月接受ES的397例异常胎儿,病历审查包括人口学、影像学和遗传学检测。

主要发现

  • 总体ES诊断率为34.3%。
  • 单发异常胎儿诊断率为31.6%,累及4个及以上主要器官系统的胎儿诊断率为42.6%。
  • 单发异常胎儿中,淋巴、颅面、骨骼和神经系统异常的ES诊断率最高。
  • 接受尸检的死胎中38.6%获得遗传学诊断。
  • 既往有受累患儿的家庭诊断率为45.5%。

临床怎么用

  • 作者认为ES应提供给存在先天性异常或发生胎儿死亡或终止妊娠的妊娠。
  • 作者指出产前ES诊断率高度依赖全面表型分析,获得诊断性ES结果后后续妊娠可选择生殖技术和检测方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the exome sequencing (ES) detection rate among fetuses with congenital anomalies and describe the rates in the setting of multiple versus isolated anomalies, perinatal autopsy, and family history of a previously affected child. METHODS: A single-center retrospective chart review was conducted on 397 anomalous fetuses that underwent ES from May 2012 through December 2023. Medical record review included demographics, imaging, and genetic testing. RESULTS: The overall ES diagnostic rate was 34.3%. The rate of diagnosis was 31.6% in fetuses with a single anomaly and 42.6% in fetuses with 4 or more major organ systems involved. Of the fetuses with a single anomaly, lymphatic, craniofacial, skeletal, and neurological anomalies had the highest diagnostic rate on ES. 38.6% of deceased fetuses who underwent autopsy had a genetic diagnosis. Additionally, families who had a previously affected child had a 45.5% diagnostic rate. CONCLUSIONS: ES is an important tool that should be offered in pregnancies affected with congenital abnormalities or at the time of fetal demise or termination. The diagnostic rate of ES in the prenatal setting is also highly dependent on comprehensive phenotyping. With diagnostic ES results, reproductive technology and testing options are available in subsequent pregnancies.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Burrill N, Schindewolf E, Pilchman L, et al. Whole Exome Sequencing in a Population of Fetuses With Structural Anomalies. Prenat Diagn. 2025. PMID: 39743338. doi:10.1002/pd.6735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。